Michael K. Chapko

faculty photo
Research Professor Emeritus, Health Services


PhD   City University of New York, 1972   (Social Psychology)
BS   Carnegie Institute of Technology, 1966   (Physics)

Contact Info

email:   chapko@uw.edu

office:   1-424J

VA Puget Sound HSR&D
Metro Park West, Suite 1400
1100 Olive Way
Seattle, WA 98101

campus box:   358280 (152)
voice:   206-764-2821
fax:   206-764-2935


Michael Chapko works at the Northwest Center for Outcomes Research In Older Adults at the Health Services Research & Development Service (HSRDS) of the Department of Veterans' Affairs. He also works with the Department of Global Health MPH program.

Ambulatory care; long-term care; cost-effectiveness

Ho PM, O'Donnell CI, Bradley SM, Grunwald GK, Helfrich C, Chapko M, Liu CF, Maddox TM, Tsai TT, Jesse RL, Fihn SD, Rumsfeld JS. 1-Year Risk-Adjusted Mortality and┬áCosts of Percutaneous Coronary Intervention in┬áthe Veterans Health Administration: Insights From the VA CART Program. J Am Coll Cardiol. 2015 Jan 27;65(3):236-42. doi: 10.1016/j.jacc.2014.10.048.  PMID: 25614420

Turner AP, Chapko MK, Yanez D, Leipertz SL, Sloan AP, Whitham RH, Haselkorn JK. Access to multiple sclerosis specialty care. PM R. 2013 Dec;5(12):1044-50. doi: 10.1016/j.pmrj.2013.07.009. Epub 2013 Aug 3.  PMID: 23920332

Kozak L, Vig E, Simons C, Eugenio E, Collinge W, Chapko M. A feasibility study of caregiver-provided massage as supportive care for Veterans with cancer. J Support Oncol. 2013 Sep;11(3):133-43.  PMID: 24400393

Khera N, Storer B, Sandmaier BM, Chapko MK, Lee SJ. Costs of second allogeneic hematopoietic cell transplantation. Transplantation. 2013 Jul 15;96(1):108-15. doi: 10.1097/TP.0b013e318294caf1.  PMID: 23694949    PMCID: PMC3696423

Lee JA, Zierler BK, Liu CF, Chapko MK. Cost-effective diagnostic strategies in patients with a high, intermediate, or low clinical probability of pulmonary embolism. Vasc Endovascular Surg. 2011 Feb;45(2):113-21. Epub 2010 Aug 31.  PMID: 20810405

Chair, thesis committee for Nandita Khera
Costs of second allogeneic hematopoietic cell transplantation